483
Martin T. Taylor, DO, PhDMartin T. Taylor, DO, PhD – FDA 483, Sep 27, 2022
Record Details
An FDA inspection of Martin T. Taylor, DO, PhD in New Albany, OH, revealed significant deviations from the investigational plan for protocol M15-736. Issues included enrolling an ineligible subject, failing to report serious adverse events to the sponsor in a timely manner, and allowing unqualified study coordinators to perform critical screening and adverse event assessments. These findings indicate serious concerns regarding the integrity and safety of the clinical trial conduct.
View Company Profile
ID · c9c10ab5-879f-40d9-9342-6e58464f7c38
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.